Follow-The-Filings

Security · featured owners

LBRX Lb Pharmaceuticals Inc.

Health Care COM SHS Equity as of 2026 Q2 among managers we track

  • 1 exit

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management exited 2026 Q2 last 2026 Q1 0.05% Exit −0.05% 14,506 $358K history

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02,7.01,9.01
424B3
8-K 2.02,9.01
10-Q
424B3
8-K 1.01,3.02,7.01,9.01
424B3
8-K 8.01,9.01
424B3
8-K 5.02,9.01
424B3
8-K 5.07
424B3
8-K 2.02,9.01
10-Q
424B3
DEFA14A
424B3
S-1
8-K 2.02,9.01
10-K
8-K 5.02
8-K 5.02,7.01,9.01
8-K 1.01,3.02,7.01,8.01,9.01
8-K 1.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 6 rows shown

Filed Form Detail Links
4 Period Jul 30, 2026
4 Period Jun 3, 2026 · 7 forms
4 Period Mar 6, 2026
4 Period Feb 6, 2026
4 Period Dec 10, 2025
4 Period Sep 10, 2025

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2025
Net income -$25.2M

Balance sheet

Metric FY2025
Total current assets $308.43M
Total non-current assets * $4.5M
Total assets $312.93M
Total current liabilities $7.44M
Total non-current liabilities * $4.18M
Total equity $301.31M

Cash flow

Metric FY2025
Cash from operations -$35.21M
Cash from investing -$39.89M
Cash from financing $302.56M
Net change in cash $227.47M

ownership over time

filing count by report period · click a bar for that quarter’s holders

period archive